CAH vs HLF
Cardinal Health Inc. and Herbalife Ltd., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | CAH | HLF |
|---|---|---|
| Revenue | $254.2B | $5.0B |
| Net income | $1.7B | $228.3M |
| Gross margin | 3.8% | 77.9% |
| Net margin | 0.7% | 4.5% |
| Return on equity | — | — |
| Diluted EPS | $7.23 | $2.20 |
| Dividend / share | $2.04 | — |
| Payout ratio | 28.6% | — |
| Free cash flow | $4.5B | $252.9M |
| Equity | $-2.9B | $-515.1M |
| Net debt / equity | — | — |
| Current ratio | 0.88× | 1.13× |
| Revenue CAGR 5y | 9.4% | −1.9% |
| Profit CAGR 5y | 22.9% | −9.3% |
CAH bills 50.5× the revenue of HLF, and HLF keeps more of each dollar of revenue as profit (4.5% against 0.7%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Revenue by year
10 years side by side
| Fiscal year | CAH | HLF |
|---|---|---|
| FY2025 | $254.2B | $5.0B |
| FY2024 | $222.6B | $5.0B |
| FY2023 | $226.8B | $5.1B |
| FY2022 | $205.0B | $5.2B |
| FY2021 | $181.3B | $5.8B |
| FY2020 | $162.5B | $5.5B |
| FY2019 | $152.9B | $4.9B |
| FY2018 | $145.5B | $4.9B |
| FY2017 | $136.8B | $4.4B |
| FY2016 | $130.0B | $4.5B |
Net income by year
Bottom line
| Fiscal year | CAH | HLF |
|---|---|---|
| FY2025 | $1.7B | $228.3M |
| FY2024 | $1.6B | $254.3M |
| FY2023 | $852.0M | $142.2M |
| FY2022 | $330.0M | $321.3M |
| FY2021 | $-938.0M | $447.2M |
| FY2020 | $611.0M | $372.6M |
| FY2019 | $-3.7B | $311.0M |
| FY2018 | $1.4B | $296.6M |
| FY2017 | $256.0M | $213.9M |
| FY2016 | $1.3B | $260.0M |